Humoral response to SARS-CoV-2 vaccines in people living with HIV
ConclusionWe found a robust antibody response in people living with HIV undergoing standard vaccination against SARS-CoV-2. mRNA-containing vaccination schemes, being female, and having a higher CD4 cell count was associated with a higher concentration of antibodies in people living with HIV in our study sample. Particularly in the subgroup with CD4 cell counts < 200 cells/µL, antibody response was poor.
Source: Infection - Category: Infectious Diseases Source Type: research